Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Julie Sarno Owens, Chelsea L. Hustus, Elise L. Everly, Steven W. Evans & Samantha M. Margherio. 2022. Comprehensive Clinical Psychology. Comprehensive Clinical Psychology
395
411
.
Rebekah Carney & Joseph Firth. (2021) Exercise interventions in child and adolescent mental health care: An overview of the evidence and recommendations for implementation. JCPP Advances 1:4.
Crossref
Crossref
Sarra Jazi, Leila Ben-Amor, Pascale Abadie, Marie-Line Menard, Rachel Choquette, Claude Berthiaume, Laurent Mottron & Drigissa Ilies. (2020) Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Métabolique à Long Terme des Jeunes Traités par Antipsychotiques de Deuxième Génération, Cinq ans Après la publication des Lignes Directrices Camesa: Faisons-Nous des Progrès?. The Canadian Journal of Psychiatry 66:7, pages 645-656.
Crossref
Crossref
Shijia Li, Min Zhuo, Xia Huang, Yuanyuan Huang, Jing Zhou, Dongsheng Xiong, Jiahui Li, Ya Liu, Zhilin Pan, Hehua Li, Jun Chen, Xiaobo Li, Zhiming Xiang, Fengchun Wu & Kai Wu. (2020) Altered gut microbiota associated with symptom severity in schizophrenia. PeerJ 8, pages e9574.
Crossref
Crossref
Yuriy Sivolap & Anna Portnova. (2020) Excessive use of antipsychotics as a global problem of clinical medicine. Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery):5, pages 9-16.
Crossref
Crossref
Nicolae-Marius Cason, Petru Aurel Babeș, Enikő Béres & Katalin Babeș. (2019) The Relative Risk of Developing Type 2 Diabetes Mellitus in Young Adults with Schizophrenia Treated with Different Atypical Antipsychotic. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 26:4, pages 445-453.
Crossref
Crossref
Karsten Gjessing Jensen, Christoph U. Correll, Ditte Rudå, Dea Gowers Klauber, Marie Stentebjerg Decara, Birgitte Fagerlund, Jens Richardt Møllegaard Jepsen, Frank Eriksson, Anders Fink-Jensen & Anne Katrine Pagsberg. (2019) Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial. Journal of the American Academy of Child & Adolescent Psychiatry 58:11, pages 1062-1078.
Crossref
Crossref
Pełka-Wysiecka, Kaczmarczyk, Bąba-Kubiś, Liśkiewicz, Wroński, Skonieczna-Żydecka, Marlicz, Misiak, Starzyńska, Kucharska-Mazur, Łoniewski & Samochowiec. (2019) Analysis of Gut Microbiota and Their Metabolic Potential in Patients with Schizophrenia Treated with Olanzapine: Results from a Six-Week Observational Prospective Cohort Study. Journal of Clinical Medicine 8:10, pages 1605.
Crossref
Crossref
Ryan S. Sultan, Shuai Wang, Stephen Crystal & Mark Olfson. (2019) Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder. JAMA Network Open 2:7, pages e197850.
Crossref
Crossref
Karolina Skonieczna-Żydecka, Igor Łoniewski, Agata Misera, Ewa Stachowska, Dominika Maciejewska, Wojciech Marlicz & Britta Galling. (2018) Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome. Psychopharmacology 236:5, pages 1491-1512.
Crossref
Crossref
A. A. Portnova & Yu. P. Sivolap. (2019) Challenges of the use of antipsychotics in children and adolescents. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:11, pages 123.
Crossref
Crossref
Hankil Lee, Dong-Ho Song, Jin-Won Kwon, Euna Han, Min-Jung Chang & Hye-Young Kang. (2018) Assessing the risk of type 2 diabetes mellitus among children and adolescents with psychiatric disorders treated with atypical antipsychotics: a population-based nested case–control study. European Child & Adolescent Psychiatry 27:10, pages 1321-1334.
Crossref
Crossref
Miquel Bioque, M.a Paz García-Portilla, Clemente García-Rizo, Bibiana Cabrera, Antonio Lobo, Ana González-Pinto, Covadonga M. Díaz-Caneja, Iluminada Corripio, Eduard Vieta, Josefina Castro-Fornieles, Julio Bobes, Miguel Gutiérrez-Fraile, Roberto Rodriguez-Jimenez, Gisela Mezquida, Adrián Llerena, Jeronimo Saiz-Ruiz & Miguel Bernardo. (2018) Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis. Schizophrenia Research 193, pages 188-196.
Crossref
Crossref
Drigissa Ilies, Anne-Sophie Huet, Eric Lacourse, Geneviève Roy, Emmanuel Stip & Leila Ben Amor. (2017) Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective Study. The Canadian Journal of Psychiatry 62:12, pages 827-836.
Crossref
Crossref
Christina Power SjoAnne Dorte StenstrømAnders Bo BojesenJacob Stampe FrølichNiels Bilenberg. (2017) Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment. Journal of Child and Adolescent Psychopharmacology 27:10, pages 884-891.
Crossref
Crossref
Christoph U. Correll & Britta Galling. (2017) Polypharmacy in Youth Treated With Antipsychotics: Do Antidepressants or Stimulants Add to the Risk for Type 2 Diabetes?. Journal of the American Academy of Child & Adolescent Psychiatry 56:8, pages 634-635.
Crossref
Crossref
Leila Jahangard, Shahrokh Akbarian, Mohammad Haghighi, Mohammad Ahmadpanah, Amir Keshavarzi, Hafez Bajoghli, Dena Sadeghi Bahmani, Edith Holsboer-Trachsler & Serge Brand. (2017) Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed – Results from a randomized, double-blind, placebo-controlled clinical trial. Psychiatry Research 251, pages 182-191.
Crossref
Crossref
Simone Pisano, Gennaro Catone, Stefania Veltri, Valentina Lanzara, Marco Pozzi, Emilio Clementi, Raffaella Iuliano, Maria Pia Riccio, Sonia Radice, Massimo Molteni, Annalisa Capuano, Antonella Gritti, Giangennaro Coppola, Annarita Milone, Carmela Bravaccio & Gabriele Masi. (2016) Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists. Italian Journal of Pediatrics 42:1.
Crossref
Crossref
Antony Loebel, Matthew Brams, Robert S. Goldman, Robert Silva, David Hernandez, Ling Deng, Raymond Mankoski & Robert L. Findling. (2015) Lurasidone for the Treatment of Irritability Associated with Autistic Disorder. Journal of Autism and Developmental Disorders 46:4, pages 1153-1163.
Crossref
Crossref
U Anyanwagu, I Idris & R Donnelly. (2016) Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism. Clinical Pharmacology & Therapeutics 99:4, pages 390-400.
Crossref
Crossref
Tina GurnaniIliyan IvanovJeffrey H. Newcorn. (2016) Pharmacotherapy of Aggression in Child and Adolescent Psychiatric Disorders. Journal of Child and Adolescent Psychopharmacology 26:1, pages 65-73.
Crossref
Crossref
P. Chue & J. Chue. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
35
54
.
Davy Vancampfort, Richard I.G. Holt, Brendon Stubbs, Marc De Hert, Katherine Samaras & Alex J. Mitchell. 2016. Life-Threatening Effects of Antipsychotic Drugs. Life-Threatening Effects of Antipsychotic Drugs
255
278
.
Antonio M. Persico, Celso Arango, Jan K. Buitelaar, Christoph U. Correll, Jeffrey C. Glennon, Pieter J. Hoekstra, Carmen Moreno, Benedetto Vitiello, Jacob Vorstman & Alessandro Zuddas. (2015) Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives. European Neuropsychopharmacology 25:10, pages 1513-1531.
Crossref
Crossref